Berkeley, CA, United States of America

Kim Huard

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 12.1

ph-index = 5

Forward Citations = 81(Granted Patents)


Location History:

  • Medford, MA (US) (2016 - 2019)
  • Berkeley, CA (US) (2020 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Kim Huard: Innovating GLP-1 Receptor Agonists

Introduction

Kim Huard, based in Berkeley, CA, is a notable inventor with a remarkable portfolio of 20 patents. His contributions to the field of pharmacology and biochemistry are reshaping the landscape of medical treatments, particularly through his work with GLP-1 receptor agonists.

Latest Patents

Among his latest groundbreaking patents are the formulations of 6-carboxylic acids of benzimidazoles and various derivatives, including 4-aza-, 5-aza-, and 7-aza-benzimidazoles as GLP-1 receptor agonists. These patents describe the processes to synthesize these compounds and detail methods for administering them to mammals in need, showcasing significant potential for diabetes and obesity treatments.

Career Highlights

Kim Huard is currently associated with Pfizer Corporation, a leading pharmaceutical company where innovative research plays a crucial role. His extensive work in the field has led to numerous patents that serve as vital tools in drug development, aiding in the discovery of effective therapies.

Collaborations

Throughout his career, Huard has collaborated with talented colleagues like Kentaro Futatsugi and Matthew Scott Dowling. These partnerships highlight the collaborative nature of pharmaceutical research, illustrating how teamwork can lead to transformative advancements in healthcare.

Conclusion

Kim Huard exemplifies the spirit of innovation within the pharmaceutical industry. His impactful patents and collaborations signify a commitment to addressing critical health challenges through research and development. As advancements continue, Huard’s contributions will likely remain influential in the ongoing quest for effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…